Biotech Updates

GM Torenia with Enhanced Phosphate Uptake

July 11, 2008

Florigene Pty ltd. has submitted an application to Australia's Office of the Gene Technology Regulator (OGTR) for the limited and controlled release of three torenia lines genetically modified for enhanced phosphate uptake. Torenia, often called wishbone flower, is a member of the family Scrophulariaceae and is commonly grown as a garden plant. The purpose of the trial is to conduct experiments with the GM lines to assess their capacity to absorb phosphate and repress algal overgrowth in a hydroponic system. The GM lines contain the phosphate signaling response gene, PHR1, from Arabidopsis which encodes a transcription factor that plays a role in plant responses to phosphate deficiency. OGTR has prepared a Risk Assessment and Risk Management Plan (RARMP) which concludes that the release of the GM torenia poses negligible risk to human health and safety, or to the environment.

To finalize the RARMP, which will be the basis of the decision on whether to issue a license, OGTR seeks comments and advice regarding the release.

For more information, visit http://www.ogtr.gov.au/ir/dir084.htm